Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2018, Article ID 7863520, 8 pages
https://doi.org/10.1155/2018/7863520
Research Article

Experience and Expectations of Ovarian Cancer Patients in Australia

Centre for Community-Driven Research, Ultimo, NSW, Australia

Correspondence should be addressed to Catherine M. Holliday; gro.rd-cc@yadillohmc and Anne T. Holliday; gro.rd-cc@yadilloha

Received 27 November 2017; Accepted 31 January 2018; Published 7 March 2018

Academic Editor: John R. Van Nagell

Copyright © 2018 Catherine M. Holliday et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. O. Smith, M. Berwick, C. F. Verschraegen et al., “Incidence and survival rates for female malignant germ cell tumors,” Obstetrics & Gynecology, vol. 107, no. 5, pp. 1075–1085, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Prat, “New insights into ovarian cancer pathology,” Annals of Oncology, vol. 23, supplement 10, pp. x111–x117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Carey, M. Bacon, D. Tu, L. Butler, A. Bezjak, and G. C. Stuart, “The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer,” Gynecologic Oncology, vol. 108, no. 1, pp. 100–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. U. A. Matulonis, A. M. Oza, T. W. Ho, and J. A. Ledermann, “Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials,” Cancer, vol. 121, no. 11, pp. 1737–1746, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. F. Hsieh and S. E. Shannon, “Three approaches to qualitative content analysis,” Qualitative Health Research, vol. 15, no. 9, pp. 1277–1288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. E. Hill, B. J. Thompson, and E. N. Williams, “A Guide to Conducting Consensual Qualitative Research,” The Counseling Psychologist, vol. 25, no. 4, pp. 517–572, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. D. K. Armstrong, B. Bundy, L. Wenzel et al., “Intraperitoneal cisplatin and paclitaxel in ovarian cancer,” The New England Journal of Medicine, vol. 354, no. 1, pp. 34–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ozga, C. Aghajanian, S. Myers-Virtue et al., “A systematic review of ovarian cancer and fear of recurrence,” Palliative & Supportive Care, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. U. A. Matulonis, A. Kornblith, H. Lee et al., “Long-term adjustment of early-stage ovarian cancer survivors,” International Journal of Gynecological Cancer, vol. 18, no. 6, pp. 1183–1193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Stewart, S. Duff, F. Wong, C. Melancon, and A. M. Cheung, “The views of ovarian cancer survivors on its cause, prevention, and recurrence.,” Medscape Women's Health, vol. 6, no. 5, p. 5, 2001. View at Google Scholar · View at Scopus
  11. A. Oza, “Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective,” Current Oncology, vol. 18, no. 6, 2011. View at Publisher · View at Google Scholar
  12. B. Ferrell, C. A. Cullinane, K. Ervin, C. Melancon, G. C. Uman, and G. Juarez, “Perspectives on the impact of ovarian cancer: Women's views of quality of life,” Oncology Nursing Forum, vol. 32, no. 6, pp. 1143–1149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Chene, G. Lamblin, K. Le Bail-Carval, P. Chabert, N. Bakrin, and G. Mellier, “Early preinvasive lesions in ovarian cancer,” BioMed Research International, vol. 2014, Article ID 639252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. W. W. Lim, D. Mesher, A. Gentry-Maharaj et al., “Time to diagnosis of Type i or II invasive epithelial ovarian cancers: A multicentre observational study using patient questionnaire and primary care records,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 123, no. 6, pp. 1012–1020, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L. N. Arriba, A. N. Fader, H. E. Frasure, and V. E. Von Gruenigen, “A review of issues surrounding quality of life among women with ovarian cancer,” Gynecologic Oncology, vol. 119, no. 2, pp. 390–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Coleman, R. Alvarez, and T. Herzog, “Endpoints in clinical trials: What do our patients consider important? A survey of the Ovarian Cancer National Alliance (OCNA),” Gynecologic Oncology, vol. 130, no. 1, p. e13, 2013. View at Publisher · View at Google Scholar
  17. L. Elit, C. Charles, I. Gold et al., “Women's perceptions about treatment decision making for ovarian cancer,” Gynecologic Oncology, vol. 88, no. 2, pp. 89–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ziebland, J. Evans, and A. McPherson, “The choice is yours? How women with ovarian cancer make sense of treatment choices,” Patient Education and Counseling, vol. 62, no. 3, pp. 361–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Luketina, C. Fotopoulou, R.-R. Luketina, A. Pilger, and J. Sehouli, “Treatment decision-making processes in the systemic treatment of ovarian cancer: Review of the scientific evidence,” Anticancer Reseach, vol. 32, no. 9, pp. 4085–4090, 2012. View at Google Scholar · View at Scopus
  20. M. I. Fitch, K. Deane, and D. Howell, “Living with ovarian cancer: women's perspectives on treatment and treatment decision-making,” Clinical Journal of Oncology Nursing, vol. 13, no. 1, pp. 8–20, 2003. View at Google Scholar
  21. M. R. Andersen, E. Sweet, K. A. Lowe, L. J. Standish, C. W. Drescher, and B. A. Goff, “Involvement in decision-making about treatment and ovarian cancer survivor quality of life,” Gynecologic Oncology, vol. 124, no. 3, pp. 465–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Armstrong, B. Weber, P. A. Ubel, N. Peters, J. Holmes, and J. S. Schwartz, “Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations,” Journal of Clinical Oncology, vol. 23, no. 36, pp. 9319–9328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. L. M. Budden, B. A. Hayes, and P. G. Buettner, “Women's decision satisfaction and psychological distress following early breast cancer treatment: A treatment decision support role for nurses,” International Journal of Nursing Practice, vol. 20, no. 1, pp. 8–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. H. Halbert, L. Kessler, A. Collier et al., “Low rates of african american participation in genetic counseling and testing for BRCA1/2 mutations: Racial disparities or just a difference?” Journal of Genetic Counseling, vol. 21, no. 5, pp. 676–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. W. Hooker, L. King, L. VanHusen et al., “Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers,” Hereditary Cancer in Clinical Practice, vol. 12, no. 1, article no. 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. V. L. Beesley, A. C. Green, D. K. Wyld et al., “Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis,” Gynecologic Oncology, vol. 132, no. 1, pp. 130–136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. F. F. Teng, S. E. Kalloger, L. Brotto, and J. N. McAlpine, “Determinants of Quality of Life in Ovarian Cancer Survivors: A Pilot Study,” Journal of Obstetrics and Gynaecology Canada, vol. 36, no. 8, pp. 708–715, 2014. View at Publisher · View at Google Scholar
  28. P. Bacchetti, C. E. McCulloch, and M. R. Segal, “Simple, defensible sample sizes based on cost efficiency,” Biometrics, vol. 64, no. 2, pp. 577–585, 2008. View at Publisher · View at Google Scholar · View at Scopus